Arbutus Biopharma Corporation ABUS Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's net change in cash?
- Arbutus Biopharma Corporation (ABUS) reported net change in cash of $5.7M in Q1 2026.
- How has Arbutus Biopharma Corporation's net change in cash changed year-over-year?
- Arbutus Biopharma Corporation's net change in cash increased by 663.8% year-over-year, from $746K to $5.7M.
- What is the long-term trend for Arbutus Biopharma Corporation's net change in cash?
- Over 2 years (2021 to 2025), Arbutus Biopharma Corporation's net change in cash has grown at a -43.3% compound annual growth rate (CAGR), from $57.03M to -$18.32M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.